You are here

Home » Content

Kateterle İlişkili Bakteriyemiden Korunmada Kateter Kapama Solüsyonlarının Kullanılması

Use of Catheter Lock Solutions to Prevent Catheter-Related Bacteremia

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Catheter-related bacteremia is a frequent complication and an important source of morbidity and mortality in hemodialysis patients. A number of well-designed, controlled, prospective trials using antimicrobial catheter lock solutions to prevent catheter-related bacteremia have shown a significant decrease in infection and infection related mortality. Despite evidence of significant benefit, these locks are not routinely used in our country. This review describes the epidemic problem of catheter-related bacteremia and discusses current options for using catheter lock solutions in the hemodialysis population.
Bookmark/Search this post with
Abstract (Original Language): 
Kateterle ilişkili bakteriyemi (KİB) hemodiyaliz hastalarında sık bir komplikasyon olmakla birlikte morbidite ve mortalitenin de önemli bir nedenidir. KİB’den korunmada antimikrobiyal kateter kapama solüsyonlarının kullanılması ile ilgili yapılan iyi dizayn edilmiş, kontrollü, prospektif klinik çalışmalar bu hastalarda infeksiyon ve infeksiyon ile ilişkili mortaliteyi azalttıkları gösterilmiştir. Tüm bu yararlı etkilerine rağmen bu solüsyonlar ülkemizde rutin olarak kullanılmamaktadır. Bu derleme hemodiyaliz hastalarında KİB ile ilgili epidemik problemleri tarif etmekte ve bu amaçla kullanılabilecek kateter kapama solusyonları hakkında güncel bilgileri içermektedir.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_18_pp_30-34.pdf
  • 1
30-34
  • Turkish

REFERENCES

References: 

1. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J:
Hemodialysis infection prevention with polysporin ointment. J Am
Soc Nephrol 2003;14: 169–179
2. Bleyer A: Use of antimicrobial catheter Lock solutions to prevent
catheter-related bacteremia. Clin J Am Soc Nephrol 2007;2: 1073-
1078
3. Allon M: Prophylaxis against dialysis catheter-related bacteremia:
A Glimmer of Hope Treatment. Am J Kidney Dis 2008; 51: 2, 165-
168
4. Lee T, Barker J, Allon M: Tunneled catheters in hemodialysis
patients: Reasons and subsequent outcomes. Am J Kidney Dis
2005;46:501-508
5. Jaffer Y, Selby NM, TaalMW, et al:A meta-analysis of hemodialysis
catheter locking solutions in the prevention of catheter-related
infection. Am J Kidney Dis 2008;51:233-241
6. Dogra GK, Herson H, Hutchison B, et al: Prevention of tunneled
hemodialysis catheter-related infections using catheterrestricted
filling with gentamicin and citrate: a randomized controlled study.
JAm Soc Nephrol 2002;13:2133-2139
7. Kim SH, Song KI, Chang JW, et al: Prevention of uncuffed
hemodialysis catheter-related bacteremia using an antibiotic lock
technique: A prospective randomized clinical trial. Kidney Int
2006;69:161-164
8. McIntyre CW, Hulme LJ, Taal M, et al: Locking of tunneled
hemodialysis catheters with gentamicin and heparin. Kidney Int
2004;66:801-805
9. Nori US, Manoharan A, Yee J, et al: Comparison of low-dose
gentamicin with minocycline as catheter lock solutions in the
prevention of catheter-related bacteremia. Am J Kidney Dis
2006;48:596-605
10. Saxena AK, Panhotra BR, Sundaram DS, et al: Enhancing the
survival of tunneled hemodialysis catheters using an antibiotic lock
in the elderly: a randomised, doubleblind clinical trial. Nephrology
(Carlton) 2006;11:299-305
11. Betjes MGH, van Agteren M: Prevention of dialysis catheterrelated
sepsis with a citrate-taurolidine-containing lock solution.
Nephrol Dial Transplant 2004;19:1546-1551
12. Weijmer MC, Van den Dorpel A, Van de Ven PJG, et al:
Randomized, clinical trial comparison of trisodium citrate 30% and
heparin as catheter-locking solution in hemodialysis patients. JAm
Soc Nephrol 2005;16:2769-2777
13. FDA issues warning on tricitrasol dialysis catheter anticoagulant.
Available at http://.fda.gov/bbs/topics/ ANSWERS/ANS01009.
html. Accessed July 26, 2007
14. Fluck R, McIntyre C, Taal M: A one-year experience single center
with antibiotic locking for tunneled venous catheters [Abstract]. J
Am Soc Nephrol 2006;17: SA-PO069
15. Zhang P, Zhang W, He Q, Yuan J, Xie W, Jiang W, Jiang H, Chen
J: A randomized controlled study on prevention of cuff-tunneled
catheter related bacteremia with gentamicinheparin lock solution:
The metaphase result [Abstract]. J Am Soc Nephrol 2006;17: SAPO073
16. Feely T, Coppley A, Bleyer AJ: Catheter lock solutions to prevent
blood stream infections in high risk HD patients. Am J Nephrol
2007;27: 24–29
17. Saxena AK, Panhotra BR, Naguib M: Sudden irreversible sensoryneural
hearing loss in a patient with diabetes receiving amikacin as
an antibiotic-heparin lock. Pharmacotherapy 2002;22: 105–108
18. Stryjewski ME, Szczech LA, Benjamin DK, Inrig JK, Kanafani
ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR,
Fowler VG: Use of vancomycin or first-generation cephalosporins
for treatment of hemodialysis-dependent patients with methicillinsusceptible
Staphylococcus aureus bacteremia. Clin Infect Dis
2007;44: 190–196
19. Klevens RM, Tokars JI, Andrus M: Electronic reporting of
infections associated with hemodialysis. Nephrol News Issues
2005;19: 37–38, 43
20. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in
dialysis patients: Incidence, risk factors, and prognosis. Kidney Int
1999;55: 1081–1090
21. Nassar GM, Ayus JC: Infectious complications of the hemodialysis
access. Kidney Int 2001;60: 1–13
22. Saxena AK, Panhotra BR: The impact of catheter-restricted
filling with cefotaxime and heparin on the lifespan of temporary
hemodialysis catheters: A case controlled study. J Nephrol 2005;18:
755–763
23. Chiou PF, Chang C, Wen YK, Yang Y: Antibiotic lock technique
reduces the incidence of temporary catheterrelated infections. Clin
Nephrol 2006;65: 419–422
24. Reaven NL: Cost of hemodialysis catheter-related complications.
JAm Soc Nephrol 2003;14:243A, (abstr)

Thank you for copying data from http://www.arastirmax.com